Following almost non-effective endogenous IFN-α/λ3 (Figures 5A, G), exogenous IFN-α/ω and IFN-λ3 pre-treatment with high biological activity failed to inhibit the viral infection and early replication in vitro (Figures 1A, B). This evidence concerns the gene IFNA1 and viral infectious disease.